Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (445) 445
Book / eBook (4) 4
Conference Proceeding (4) 4
Newspaper Article (3) 3
Book Chapter (1) 1
Electronic Resource (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (265) 265
life sciences & biomedicine (252) 252
humans (237) 237
female (140) 140
oncology (127) 127
male (124) 124
middle aged (113) 113
biological and medical sciences (108) 108
aged (98) 98
adult (95) 95
medical sciences (91) 91
breast cancer (71) 71
abridged index medicus (66) 66
tumors (65) 65
breast neoplasms - drug therapy (58) 58
prostate cancer (49) 49
treatment outcome (48) 48
cancer (47) 47
research (45) 45
care and treatment (39) 39
chemotherapy, adjuvant (39) 39
nephrology. urinary tract diseases (38) 38
aged, 80 and over (36) 36
prognosis (36) 36
tumors of the urinary system (36) 36
disease-free survival (35) 35
antineoplastic agents, hormonal - therapeutic use (34) 34
antineoplastic combined chemotherapy protocols - therapeutic use (34) 34
chemotherapy (34) 34
clinical trials (32) 32
tamoxifen (32) 32
health aspects (31) 31
tamoxifen - therapeutic use (31) 31
urinary tract. prostate gland (31) 31
analysis (30) 30
gynecology. andrology. obstetrics (30) 30
urology & nephrology (30) 30
breast neoplasms - pathology (27) 27
patients (27) 27
prostatic neoplasms - pathology (27) 27
retrospective studies (27) 27
risk factors (26) 26
prostate-specific antigen - blood (24) 24
quality of life (24) 24
time factors (24) 24
animals (23) 23
neoplasm staging (23) 23
amino acids (20) 20
breast neoplasms - genetics (20) 20
follow-up studies (20) 20
prospective studies (20) 20
prostatic neoplasms - blood (20) 20
surgery (20) 20
tamoxifen - administration & dosage (20) 20
breast neoplasms - mortality (19) 19
medical research (19) 19
predictive value of tests (19) 19
survival analysis (19) 19
urology (19) 19
breast neoplasms - surgery (18) 18
fundamental and applied biological sciences. psychology (18) 18
hematology, oncology and palliative medicine (18) 18
double-blind method (17) 17
male genital diseases (17) 17
original reports (17) 17
randomized controlled trials as topic (17) 17
antineoplastic agents (16) 16
antineoplastic agents - therapeutic use (16) 16
aromatase inhibitors - therapeutic use (16) 16
diet (16) 16
general & internal medicine (16) 16
immunohistochemistry (16) 16
kaplan-meier estimate (16) 16
nutrition & dietetics (16) 16
nutritional requirements (16) 16
oxidation-reduction (16) 16
premenopause (16) 16
risk assessment (16) 16
studies (16) 16
breast neoplasms - metabolism (15) 15
endocrine therapy (15) 15
genetic aspects (15) 15
pharmacology. drug treatments (15) 15
physiological aspects (15) 15
postmenopause (15) 15
prostatic neoplasms - drug therapy (15) 15
receptors, estrogen - metabolism (15) 15
antineoplastic agents, hormonal - administration & dosage (14) 14
biopsy (14) 14
medical colleges (14) 14
medicine & public health (14) 14
metastasis (14) 14
oncology, experimental (14) 14
prostatic neoplasms - genetics (14) 14
surveys and questionnaires (14) 14
cancer and oncology (13) 13
cancer och onkologi (13) 13
cancer therapies (13) 13
cohort studies (13) 13
genotype (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
by Heng, Daniel YC, Dr and Xie, Wanling, MS and Regan, Meredith M, ScD and Harshman, Lauren C, MD and Bjarnason, Georg A, MD and Vaishampayan, Ulka N, MD and Mackenzie, Mary, MD and Wood, Lori, MD and Donskov, Frede, MD and Tan, Min-Han, MD and Rha, Sun-Young, MD and Agarwal, Neeraj, MD and Kollmannsberger, Christian, MD and Rini, Brian I, Prof and Choueiri, Toni K, MD
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 2, pp. 141 - 148
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Reproducibility of Results | Prognosis | Carcinoma, Renal Cell - pathology | Humans | Middle Aged | Male | Survival Rate | Kidney Neoplasms - mortality | Kidney Neoplasms - diagnosis | Carcinoma, Renal Cell - mortality | Neoplasm Metastasis | Models, Biological | Carcinoma, Renal Cell - diagnosis | Female | Kidney Neoplasms - pathology | Aged | Databases, Factual | Consortia | Databases | Carcinoma | Models | Metastasis | Nanotechnology | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
by Galimberti, Viviana, Dr and Cole, Bernard F, PhD and Zurrida, Stefano, MD and Viale, Giuseppe, MD and Luini, Alberto, MD and Veronesi, Paolo, MD and Baratella, Paola, MD and Chifu, Camelia, MD and Sargenti, Manuela, MD and Intra, Mattia, MD and Gentilini, Oreste, MD and Mastropasqua, Mauro G, MD and Mazzarol, Giovanni, MD and Massarut, Samuele, MD and Garbay, Jean-Rémi, MD and Zgajnar, Janez, MD and Galatius, Hanne, MD and Recalcati, Angelo, MD and Littlejohn, David, FRACS and Bamert, Monika, MD and Colleoni, Marco, MD and Price, Karen N, BS and Regan, Meredith M, SD and Goldhirsch, Aron, MD and Coates, Alan S, MD and Gelber, Richard D, PhD and Veronesi, Umberto, MD and for the International Breast Cancer Study Group Trial 23–01 investigators and Int Breast Canc Study Grp Trial 23 and International Breast Cancer Study Group Trial 23-01 investigators
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 4, pp. 297 - 305
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - surgery | Lymph Nodes - pathology | Follow-Up Studies | Lymph Nodes - surgery | Humans | Middle Aged | Treatment Outcome | Lymphatic Metastasis | Breast Neoplasms - physiopathology | Disease-Free Survival | Neoplasm Grading | Neoplasm Micrometastasis | Breast Neoplasms - pathology | Axilla | Adult | Female | Aged | Sentinel Lymph Node Biopsy | Surgery | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials
by Bernhard, Jürg, Dr and Luo, Weixiu, MD and Ribi, Karin, PhD and Colleoni, Marco, MD and Burstein, Harold J, MD and Tondini, Carlo, MD and Pinotti, Graziella, MD and Spazzapan, Simon, MD and Ruhstaller, Thomas, MD and Puglisi, Fabio, MD and Pavesi, Lorenzo, MD and Parmar, Vani, MBBS and Regan, Meredith M, ScD and Pagani, Olivia, MD and Fleming, Gini F, MD and Francis, Prudence A, MD and Price, Karen N, BS and Coates, Alan S, MD and Gelber, Richard D, PhD and Goldhirsch, Aron, MD and Walley, Barbara A, MD
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 848 - 858
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Dose-Response Relationship, Drug | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Invasiveness - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Adult | Female | Ovary - drug effects | Chemotherapy, Adjuvant | Drug Administration Schedule | Risk Assessment | Administration, Oral | Early Detection of Cancer | Self Report | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - pathology | Tamoxifen - therapeutic use | Premenopause - physiology | Survival Analysis | Quality of Life | Breast Neoplasms - mortality | Tamoxifen - adverse effects | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Challenges of Guarantee-Time Bias
by Anita Giobbie-Hurder and Richard D. Gelber and Meredith M. Regan
Journal of clinical oncology, ISSN 0732-183X, 08/2013, Volume 31, Issue 23, pp. 2963 - 2969
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Medical Oncology - methods | ras Proteins - genetics | Amenorrhea - physiopathology | Proto-Oncogene Proteins p21(ras) | Randomized Controlled Trials as Topic - methods | Bias | Colorectal Neoplasms - genetics | Humans | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Breast Neoplasms - physiopathology | Breast Neoplasms - therapy | Disease-Free Survival | Survival Analysis | Female | Clinical Trials as Topic - methods | Mutation | Research Design | Index Medicus | Stat | Bios3 | Statistics in Oncology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
by Regan, Meredith M, Dr and Neven, Patrick, MD and Giobbie-Hurder, Anita, MS and Goldhirsch, Aron, MD and Ejlertsen, Bent, MD and Mauriac, Louis, MD and Forbes, John F, FRACS and Smith, Ian, MD and Láng, István, MD and Wardley, Andrew, MD and Rabaglio, Manuela, MD and Price, Karen N, BS and Gelber, Richard D, PhD and Coates, Alan S, MD and Thürlimann, Beat, MD and for the members of the BIG 1-98 Collaborative Group and the International Breast Cancer Study Group (IBCSG) and BIG 1-98 Collaborative Group and International Breast Cancer Study Group (IBCSG)
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1101 - 1108
Hematology, Oncology and Palliative Medicine | South America | Triazoles - administration & dosage | Breast Neoplasms - secondary | Humans | North America | Tamoxifen - administration & dosage | Nitriles - administration & dosage | Receptors, Steroid - analysis | Breast Neoplasms - chemistry | Neoplasms, Second Primary | Time Factors | Postmenopause | Female | Aromatase Inhibitors - administration & dosage | Double-Blind Method | Biomarkers, Tumor - analysis | Europe | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Selective Estrogen Receptor Modulators - administration & dosage | Treatment Outcome | Breast Neoplasms - drug therapy | Cross-Over Studies | New Zealand | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | South Africa | Australia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
by Francis, Prudence A and Regan, Meredith M and Fleming, Gini F and Láng, István and Ciruelos, Eva and Bellet, Meritxell and Bonnefoi, Hervé R and Climent, Miguel A and Da Prada, Gian Antonio and Burstein, Harold J and Martino, Silvana and Davidson, Nancy E and Geyer, Charles E and Walley, Barbara A and Coleman, Robert and Kerbrat, Pierre and Buchholz, Stefan and Ingle, James N and Winer, Eric P and Rabaglio-Poretti, Manuela and Maibach, Rudolf and Ruepp, Barbara and Giobbie-Hurder, Anita and Price, Karen N and Colleoni, Marco and Viale, Giuseppe and Coates, Alan S and Goldhirsch, Aron and Gelber, Richard D and Int Breast Canc Study Grp and SOFT Investigators and International Breast Cancer Study Group
The New England journal of medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 436 - 446
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Breast Neoplasms - surgery | Premenopause | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - drug therapy | Antineoplastic Agents, Hormonal - adverse effects | Disease-Free Survival | Aromatase Inhibitors - adverse effects | Breast Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Mastectomy | Adult | Female | Androstadienes - therapeutic use | Chemotherapy, Adjuvant | Tamoxifen - adverse effects | Androstadienes - adverse effects | Aromatase Inhibitors - therapeutic use | Chemotherapy | Womens health | Invasiveness | Estrogens | Population studies | Breast cancer | Reproductive system | Tamoxifen | Drug therapy | Survival | Patients | Statistical analysis | Endocrine therapy | Radiation therapy | Cancer therapies | Survival analysis | Health risk assessment | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
by Pagani, Olivia and Regan, Meredith M and Walley, Barbara A and Fleming, Gini F and Colleoni, Marco and Láng, István and Gomez, Henry L and Tondini, Carlo and Burstein, Harold J and Perez, Edith A and Ciruelos, Eva and Stearns, Vered and Bonnefoi, Hervé R and Martino, Silvana and Geyer, Charles E and Pinotti, Graziella and Puglisi, Fabio and Crivellari, Diana and Ruhstaller, Thomas and Winer, Eric P and Rabaglio-Poretti, Manuela and Maibach, Rudolf and Ruepp, Barbara and Giobbie-Hurder, Anita and Price, Karen N and Bernhard, Jürg and Luo, Weixiu and Ribi, Karin and Viale, Giuseppe and Coates, Alan S and Gelber, Richard D and Goldhirsch, Aron and Francis, Prudence A and TEXT SOFT Investigators Int Breast and International Breast Cancer Study Group and TEXT and SOFT Investigators
The New England journal of medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 2, pp. 107 - 118
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | General aspects | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Estradiol - blood | Breast Neoplasms - surgery | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Mastectomy | Adult | Female | Chemotherapy, Adjuvant | Aromatase Inhibitors - therapeutic use | Osteoporosis - chemically induced | Premenopause | Kaplan-Meier Estimate | Triptorelin Pamoate - adverse effects | Triptorelin Pamoate - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tamoxifen - therapeutic use | Quality of Life | Androstadienes - therapeutic use | Tamoxifen - adverse effects | Androstadienes - adverse effects | Care and treatment | Breast cancer | Research | Ovariectomy | Invasiveness | Estrogens | Radiation | Clinical trials | Data processing | Pituitary (anterior) | Gonadotropins | Tamoxifen | Survival | Patients | Clinical outcomes | Post-menopause | Chemotherapy | Aromatase | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Risk stratification according to stage and pathology
by Regan, Meredith M
Breast (Edinburgh), ISSN 0960-9776, 11/2019, Volume 48 Suppl 1, pp. S23 - S25
Neoplasm Staging - methods | Risk Assessment - methods | Biomarkers, Tumor - analysis | United States | Humans | Risk Factors | Female | Breast Neoplasms - diagnosis | Neoplasm Staging - standards | Breast - pathology | Advisory Committees | Risk Assessment - standards | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Reply to K.-D. Yu et al
by Ruhstaller, Thomas and Regan, Meredith M
Journal of clinical oncology, ISSN 0732-183X, 06/2019, Volume 37, Issue 17, pp. 1516 - 1517
Follow-Up Studies | Humans | Postmenopause | Female | Breast Neoplasms | Tamoxifen | Letrozole | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
by Giuseppe Viale and Anita Giobbie-Hurder and Meredith M. Regan and Alan S. Coates and Mauro G. Mastropasqua and Patrizia Dell'Orto and Eugenio Maiorano and Gaëtan MacGrogan and Stephen G. Braye and Christian Öhlschlegel and Patrick Neven and Zsolt Orosz and Wojciech P. Olszewski and Fiona Knox and Beat Thürlimann and Karen N. Price and Monica Castiglione-Gertsch and Richard D. Gelber and Barry A. Gusterson and Aron Goldhirsch and Breast International Group Trial 1-98 and Sahlgrenska akademin and Institute of Clinical Sciences and Institutionen för kliniska vetenskaper and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
Journal of clinical oncology, ISSN 0732-183X, 12/2008, Volume 26, Issue 34, pp. 5569 - 5575
Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Predictive Value of Tests | Prognosis | Humans | Proportional Hazards Models | Antineoplastic Agents - therapeutic use | Breast Neoplasms | Endocrine System | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Postmenopause | Female | Ki-67 Antigen - biosynthesis | Chemotherapy, Adjuvant | Cohort Studies | Nitriles - therapeutic use | Triazoles - therapeutic use | Index Medicus | Breast Cancer | Antineoplastic Agents | Hormonal | Tamoxifen | Chemotherapy | Triazoles | Ki-67 Antigen | biosynthesis | Nitriles | Adjuvant | Cancer and Oncology | therapeutic use | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States
by Juan-Miguel Mosquera and Rohit Mehra and Meredith M. Regan and Sven Perner and Elizabeth M. Genega and Gerri Bueti and Rajal B. Shah and Sandra Gaston and Scott A. Tomlins and John T. Wei and Michael C. Kearney and Laura A. Johnson and Jeffrey M. Tang and Arul M. Chinnaiyan and Mark A. Rubin and Martin G. Sanda
Clinical cancer research, ISSN 1078-0432, 07/2009, Volume 15, Issue 14, pp. 4706 - 4711
Prostate cancer | Needle biopsies | TMPRSS2-ERG | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | Pharmacology. Drug treatments | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Antineoplastic agents | Male genital diseases | Tumors | Transcriptional Regulator ERG | Multivariate Analysis | Prostatic Neoplasms - pathology | Prospective Studies | United States | Gene Frequency | Humans | Middle Aged | In Situ Hybridization, Fluorescence | Logistic Models | Male | Prostate-Specific Antigen - analysis | Prostate - metabolism | Prostate - pathology | Prostatic Neoplasms - genetics | Biopsy | Oncogene Proteins, Fusion - genetics | Serine Endopeptidases - genetics | Trans-Activators - genetics | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk
by Meier-Ewert, Hans K and Ridker, Paul M and Rifai, Nader and Regan, Meredith M and Price, Nick J and Dinges, David F and Mullington, Janet M
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2004, Volume 43, Issue 4, pp. 678 - 683
Heart rate | General Clinical Research Center | C-reactive protein | Partial sleep deprivation | Interleukin | Blood pressure | Analysis of variance | Total sleep deprivation | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Humans | Male | Risk | Biomarkers - blood | Inflammation - blood | Monitoring, Physiologic | Time Factors | Cardiovascular Diseases - epidemiology | Heart Rate - physiology | Adult | Female | Blood Pressure - physiology | C-Reactive Protein - analysis | Sleep Deprivation - blood | Heart | Cytokines | Review boards | Experiments | Sleep deprivation | Studies | Proteins | Body mass index | Hypotheses | Sleep | Hospitals | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights